E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.77 -$0.04-2.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 7.36% 17.46% 7.72% 17.96% 11.20%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 5.07% 13.90% 8.51% 11.73% 11.25%
Operating Income 11.99% 3.79% 8.79% -11.73% -11.25%
Income Before Tax 37.64% 32.10% 9.09% -23.29% -23.69%
Income Tax Expenses 129.90% 130.02% -43.65% -28.14% -1,752.00%
Earnings from Continuing Operations 37.37% 31.75% 9.18% -23.28% -23.31%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -52.38% -67.71% -47.89% -62.87% -68.18%
Net Income 37.37% 31.73% 9.15% -23.39% -23.44%
EBIT 11.99% 3.79% 8.79% -11.73% -11.25%
EBITDA 12.02% 3.77% 8.81% -11.82% -11.26%
EPS Basic 45.69% 43.02% 22.09% -0.39% 1.36%
Normalized Basic EPS 40.02% 37.21% 36.01% 13.12% 10.93%
EPS Diluted 45.69% 43.02% 22.11% -0.47% 1.28%
Normalized Diluted EPS 40.00% 37.19% 35.99% 13.12% 10.93%
Average Basic Shares Outstanding 14.09% 20.58% 21.21% 23.76% 25.57%
Average Diluted Shares Outstanding 14.21% 20.71% 21.34% 23.76% 25.57%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings